General Information of Drug (ID: DMLTG2Q)

Drug Name
Trimelamol
Synonyms NSC-283162
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Discontinued in Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C9H18N6O3
Canonical SMILES
CN(CO)C1=NC(=NC(=N1)N(C)CO)N(C)CO
InChI
InChI=1S/C9H18N6O3/c1-13(4-16)7-10-8(14(2)5-17)12-9(11-7)15(3)6-18/h16-18H,4-6H2,1-3H3
InChIKey
MHVFYGIQJNFWGQ-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
92368
CAS Number
64124-21-6
TTD ID
D06EIO
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004905)